mazindol has been researched along with Colonic Inertia in 2 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Colonic Inertia: Symptom characterized by the passage of stool once a week or less.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delitala, G | 1 |
Alagna, S | 1 |
Masala, A | 1 |
Sedgwick, JP | 1 |
1 trial available for mazindol and Colonic Inertia
Article | Year |
---|---|
Maziniol in the treatment of obesity.
Topics: Body Weight; Clinical Trials as Topic; Constipation; Humans; Indoles; Mazindol; Obesity; Placebos; S | 1975 |
1 other study available for mazindol and Colonic Inertia
Article | Year |
---|---|
[Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].
Topics: Adolescent; Adult; Child; Constipation; Drug Evaluation; Female; Humans; Indoles; Male; Mazindol; Mi | 1977 |